recombinant BC-PIV viral vector vaccine (MediciNova)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant BC-PIV viral vector vaccine (MediciNova)

Drug Alias NameBC-PIV Covid-19 vaccine (Medicinova)recombinant BC-PIV viral vector vaccine (BioComo/Mie University)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMie University

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

ATC CodeN/A